{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:21:48Z","timestamp":1792448508394,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHM 3261\/3-1"],"award-info":[{"award-number":["SCHM 3261\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dr. Reinfried Pohl Foundation"},{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>C1q\/TNF-related protein 3 (CTRP3) represents an adipokine with various metabolic and immune-regulatory functions. While circulating CTRP3 has been proposed as a potential biomarker for cardiovascular disease (CVD), current data on CTRP3 regarding coronary artery disease (CAD) remains partially contradictory. This study aimed to investigate CTRP3 levels in chronic and acute settings such as chronic coronary syndrome (CCS) and acute coronary syndrome (ACS). A total of 206 patients were classified into three groups: CCS (n\u2009=\u200964), ACS having a first acute event (ACS-1, n\u2009=\u200975), and ACS having a recurrent acute event (ACS-2, n\u2009=\u200967). The control group consisted of 49 healthy individuals. ELISA measurement in peripheral blood revealed decreased CTRP3 levels in all patient groups (p\u2009&lt;\u20090.001) without significant differences between the groups. This effect was exclusively observed in male patients. Females generally exhibited significantly higher CTRP3 plasma levels than males. ROC curve analysis in male patients revealed a valuable predictive potency of plasma CTRP3 in order to identify CAD patients, with a proposed cut-off value of 51.25\u00a0ng\/mL. The sensitivity and specificity of prediction by CTRP3 were congruent for the subgroups of CCS, ACS-1, and ACS-2 patients. Regulation of circulating CTRP3 levels in murine models of cardiovascular pathophysiology was found to be partly opposite to the clinical findings, with male mice exhibiting higher circulating CTRP3 levels than females. We conclude that circulating CTRP3 levels are decreased in both male CCS and ACS patients. Therefore, CTRP3 might be useful as a biomarker for CAD but not for distinguishing an acute from a chronic setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>CTRP3 levels were found to be decreased in both male CCS and ACS patients compared to healthy controls. Plasma CTRP3 has a valuable predictive potency in order to identify CAD patients among men and is therefore proposed as a biomarker for CAD but not for distinguishing between acute and chronic settings.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Regulation of circulating CTRP3 levels in murine models of cardiovascular pathophysiology was found to be partly opposite to the clinical findings in men.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-024-02426-8","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T15:01:41Z","timestamp":1709564501000},"page":"667-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-1971","authenticated-orcid":false,"given":"Andreas","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pankuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Vlacil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Gajawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Troidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sch\u00e4ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Grote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"2426_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32007-0","author":"GR Dagenais","year":"2020","unstructured":"Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, Diaz R, Avezum A, Oliveira GBF, Wielgosz A et al (2020) Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(19)32007-0","journal-title":"Lancet"},{"key":"2426_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-020-1273-y","volume":"22","author":"AK Dwivedi","year":"2020","unstructured":"Dwivedi AK, Dubey P, Cistola DP, Reddy SY (2020) Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies. Curr Cardiol Rep 22:1\u201319","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"2426_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","volume":"11","author":"Y Rochlani","year":"2017","unstructured":"Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL (2017) Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 11(8):215\u2013225","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"11","key":"2426_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber C, Noels H (2011) Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 17(11):1410\u20131422","journal-title":"Nat Med"},{"key":"2426_CR5","doi-asserted-by":"publisher","unstructured":"Saleh M, Ambrose JA (2018) Understanding myocardial infarction.\u00a0F1000Res 7:F1000 Faculty Rev-1378. https:\/\/doi.org\/10.12688\/f1000research.15096.1","DOI":"10.12688\/f1000research.15096.1"},{"issue":"2","key":"2426_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"316","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316(2):129\u2013139","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2426_CR7","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1530\/JOE-16-0211","volume":"231","author":"L Luo","year":"2016","unstructured":"Luo L, Liu M (2016) Adipose tissue in control of metabolism. J Endocrinol 231(3):R77\u2013R99","journal-title":"J Endocrinol"},{"issue":"9","key":"2426_CR8","doi-asserted-by":"publisher","first-page":"e12997","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Rodr\u00edguez A, Becerril S, Fr\u00fchbeck G, Catal\u00e1n V (2018) Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest 48(9):e12997","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"2426_CR9","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1194\/jlr.R094060","volume":"60","author":"JB Funcke","year":"2019","unstructured":"Funcke JB, Scherer PE (2019) Beyond adiponectin and leptin: Adipose tissue-derived mediators of inter-organ communication. J Lipid Res 60(10):1648\u20131697","journal-title":"J Lipid Res"},{"issue":"4","key":"2426_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","volume":"63","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Fuster JJ, Walsh K (2014) Adipokines: A link between obesity and cardiovascular disease. J Cardiol 63(4):250\u2013259","journal-title":"J Cardiol"},{"key":"2426_CR11","doi-asserted-by":"publisher","first-page":"570270","DOI":"10.3389\/fphys.2020.570270","volume":"11","author":"B Guo","year":"2020","unstructured":"Guo B, Zhuang T, Xu F, Lin X, Li F, Shan SK, Wu F, Zhong JY, Wang Y, Zheng MH et al (2020) New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions. Front Physiol 11:570270","journal-title":"Front Physiol"},{"issue":"3","key":"2426_CR12","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.dsx.2019.04.047","volume":"13","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Rashidfarrokhi F, Atkin SL, Sahebkar A (2019) C1q\/TNF-related protein-3 and glucose homeostasis. Diabetes Metab Syndr Clin Res Rev 13(3):1923\u20131927","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2426_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.plipres.2016.10.001","volume":"64","author":"Y Yang","year":"2016","unstructured":"Yang Y, Li Y, Ma Z, Jiang S, Fan C, Hu W, Wang D, Di S, Sun Y, Yi W (2016) A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection. Prog Lipid Res 64:170\u2013177","journal-title":"Prog Lipid Res"},{"key":"2426_CR14","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1210\/en.2010-0571","volume":"151","author":"A Kopp","year":"2010","unstructured":"Kopp A, Bala M, Buechler C, Falk W, Gross P, Neumeier M, Sch\u00f6lmerich J, Sch\u00e4ffler A (2010) C1q\/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. Endocrinology 151:5267\u20135278. https:\/\/doi.org\/10.1210\/en.2010-0571","journal-title":"Endocrinology"},{"key":"2426_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2014.06.054","volume":"452","author":"A Schmid","year":"2014","unstructured":"Schmid A, Kopp A, Hanses F, Karrasch T, Sch\u00e4ffler A (2014) C1q\/TNF-related protein-3 (CTRP-3) attenuates lipopolysaccharide (LPS)-induced systemic inflammation and adipose tissue Erk-1\/-2 phosphorylation in mice in vivo. Biochem Biophys Res Commun 452:8\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2014.06.054","journal-title":"Biochem Biophys Res Commun"},{"key":"2426_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-1117-0","volume":"19","author":"C Gao","year":"2019","unstructured":"Gao C, Zhao S, Lian K, Mi B, Si R, Tan Z, Fu F, Wang S, Wang R, Ma X et al (2019) C1q\/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality. BMC Cardiovasc Disord 19:1\u20139. https:\/\/doi.org\/10.1186\/s12872-019-1117-0","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"2426_CR17","doi-asserted-by":"publisher","first-page":"e55744","DOI":"10.1371\/journal.pone.0055744","volume":"8","author":"HJ Yoo","year":"2013","unstructured":"Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Choi DS, Baik SH, Bl\u00fcher M, Youn BS, Choi KM (2013) Implication of Progranulin and C1q\/TNF-Related Protein-3 (CTRP3) on Inflammation and Atherosclerosis in Subjects with or without Metabolic Syndrome. PLoS One 8(2):e55744. https:\/\/doi.org\/10.1371\/journal.pone.0055744","journal-title":"PLoS One"},{"issue":"1","key":"2426_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-13-14","volume":"13","author":"KM Choi","year":"2014","unstructured":"Choi KM, Hwang SY, Hong HC, Choi HY, Yoo HJ, Youn BS, Baik SH, Seo HS (2014) Implications of C1q\/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc Diabetol 13(1):1\u20138. https:\/\/doi.org\/10.1186\/1475-2840-13-14","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2426_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-019-1749-0","volume":"10","author":"B Zhang","year":"2019","unstructured":"Zhang B, Zhang P, Tan Y, Feng P, Zhang Z, Liang H, Duan W, Jin Z, Wang X, Liu J et al (2019) C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38\/CREB pathway and p38-induced ER stress. Cell Death Dis 10(7):520. https:\/\/doi.org\/10.1038\/s41419-019-1749-0","journal-title":"Cell Death Dis"},{"key":"2426_CR20","doi-asserted-by":"publisher","unstructured":"Wang F, Zhao L, Shan Y, Li R, Qin G (2019) CTRP3 Protects against high glucose-induced cell injury in human umbilical vein endothelial cells.\u00a0Anal Cell Pathol (Amst) 2019:7405602. https:\/\/doi.org\/10.1155\/2019\/7405602","DOI":"10.1155\/2019\/7405602"},{"key":"2426_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11010-007-9506-6","volume":"304","author":"H Akiyama","year":"2007","unstructured":"Akiyama H, Furukawa S, Wakisaka S, Maeda T (2007) CTRP3\/cartducin promotes proliferation and migration of endothelial cells. Mol Cell Biochem 304:243\u2013248. https:\/\/doi.org\/10.1007\/s11010-007-9506-6","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"2426_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41419-019-1760-5","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhu L, Feng P, Tan Y, Zhang B, Gao E, Wang X, Fan C, Wang X, Yi W et al (2019) C1q\/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction. Cell Death Dis 10(7):530. https:\/\/doi.org\/10.1038\/s41419-019-1760-5","journal-title":"Cell Death Dis"},{"key":"2426_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00109-015-1309-8","volume":"93","author":"D Wu","year":"2015","unstructured":"Wu D, Lei H, Wang JY, Zhang CL, Feng H, Fu FY, Li L, Wu LL (2015) CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. J Mol Med 93:1311\u20131325. https:\/\/doi.org\/10.1007\/s00109-015-1309-8","journal-title":"J Mol Med"},{"key":"2426_CR24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s10753-019-00996-1","volume":"42","author":"L Chen","year":"2019","unstructured":"Chen L, Qin L, Liu X, Meng X (2019) CTRP3 Alleviates Ox-LDL\u2013Induced Inflammatory Response and Endothelial Dysfunction in Mouse Aortic Endothelial Cells by Activating the PI3K\/Akt\/eNOS Pathway. Inflammation 42:1350\u20131359. https:\/\/doi.org\/10.1007\/s10753-019-00996-1","journal-title":"Inflammation"},{"issue":"3","key":"2426_CR25","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3892\/etm.2020.8467","volume":"19","author":"H Zhu","year":"2020","unstructured":"Zhu H, Ding Y, Zhang Y, Ding X, Zhao J, Ouyang W, Gong J, Zou Y, Liu X, Wu W (2020) CTRP3 induces an intermediate switch of CD14++CD16+ monocyte subset with anti-inflammatory phenotype. Exp Ther Med 19(3):2243\u20132251. https:\/\/doi.org\/10.3892\/etm.2020.8467","journal-title":"Exp Ther Med"},{"issue":"12","key":"2426_CR26","doi-asserted-by":"publisher","first-page":"e0168773","DOI":"10.1371\/journal.pone.0168773","volume":"11","author":"R Fadaei","year":"2016","unstructured":"Fadaei R, Moradi N, Baratchian M, Aghajani H, Malek M, Fazaeli AA, Fallah S (2016) Association of C1q\/TNF-related protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes mellitus. PLoS One 11(12):e0168773. https:\/\/doi.org\/10.1371\/journal.pone.0168773","journal-title":"PLoS One"},{"issue":"12","key":"2426_CR27","doi-asserted-by":"publisher","first-page":"e0208038","DOI":"10.1371\/journal.pone.0208038","volume":"13","author":"SF Ahmed","year":"2018","unstructured":"Ahmed SF, Shabayek MI, Abdel Ghany ME, El-Hefnawy MH, El-Mesallamy HO (2018) Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females. PLoS One 13(12):e0208038. https:\/\/doi.org\/10.1371\/journal.pone.0208038","journal-title":"PLoS One"},{"key":"2426_CR28","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1038\/s41598-022-08600-7","volume":"12","author":"A Witten","year":"2022","unstructured":"Witten A, Martens L, Sch\u00e4fer A-C, Troidl C, Pankuweit S, Vlacil A-K, Oberoi R, Schieffer B, Grote K, Stoll M et al (2022) Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease. Sci Rep 12:5589. https:\/\/doi.org\/10.1038\/s41598-022-08600-7","journal-title":"Sci Rep"},{"key":"2426_CR29","doi-asserted-by":"publisher","first-page":"108453","DOI":"10.1016\/j.diabres.2020.108453","volume":"169","author":"N Moradi","year":"2020","unstructured":"Moradi N, Najafi M, Sharma T, Fallah S, Koushki M, Peterson JM, Meyre D, Fadaei R (2020) Circulating levels of CTRP3 in patients with type 2 diabetes mellitus compared to controls: A systematic review and meta-analysis. Diabetes Res Clin Pract 169:108453","journal-title":"Diabetes Res Clin Pract"},{"key":"2426_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-015-0029-0","volume":"7","author":"W Deng","year":"2015","unstructured":"Deng W, Li C, Zhang Y, Zhao J, Yang M, Tian M, Li L, Zheng Y, Chen B, Yang G (2015) Serum C1q\/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance. Diabetol Metab Syndr 7:1\u20138. https:\/\/doi.org\/10.1186\/s13098-015-0029-0","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"2426_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cphy.c160044","volume":"7","author":"Y Li","year":"2017","unstructured":"Li Y, Wright GL, Peterson JM (2017) C1q\/TNF-related protein 3 (CTRP3) function and regulation. Compr Physiol 7(3):863. https:\/\/doi.org\/10.1002\/cphy.c160044","journal-title":"Compr Physiol"},{"issue":"3","key":"2426_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/cbi20090043","volume":"34","author":"T Maeda","year":"2010","unstructured":"Maeda T, Wakisaka S (2010) CTRP3\/cartducin is induced by transforming growth factor-\u03b21 and promotes vascular smooth muscle cell proliferation. Cell Biol Int 34(3):261\u2013266. https:\/\/doi.org\/10.1042\/cbi20090043","journal-title":"Cell Biol Int"},{"issue":"7","key":"2426_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/oby.2008.206","volume":"16","author":"B W\u00f6lfing","year":"2008","unstructured":"W\u00f6lfing B, Buechler C, Weigert J, Neumeier M, Aslanidis C, Sch\u00f6elmerich J, Sch\u00e4ffler A (2008) Effects of the new C1q\/TNF-related protein (CTRP-3) \u201ccartonectin\u201d on the adipocytic secretion of adipokines. Obesity 16(7):1481\u20131486. https:\/\/doi.org\/10.1038\/oby.2008.206","journal-title":"Obesity"},{"key":"2426_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cca.2018.01.003","volume":"479","author":"W Zhou","year":"2018","unstructured":"Zhou W, Wang Y, Wu Y, Yang J, Xu L, Yang Y (2018) Serum CTRP3 level is inversely associated with nonalcoholic fatty liver disease: A 3-y longitudinal study. Clin Chim Acta 479:79\u201383. https:\/\/doi.org\/10.1016\/j.cca.2018.01.003","journal-title":"Clin Chim Acta"},{"key":"2426_CR35","doi-asserted-by":"publisher","first-page":"e2573","DOI":"10.7717\/peerj.2573","volume":"4","author":"RM Wagner","year":"2016","unstructured":"Wagner RM, Sivagnanam K, Clark WA, Peterson JM (2016) Divergent relationship of circulating CTRP3 levels between obesity and gender: A cross-sectional study. PeerJ 4:e2573. https:\/\/doi.org\/10.7717\/peerj.2573","journal-title":"PeerJ"},{"issue":"21","key":"2426_CR36","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.3390\/ijms21218168","volume":"21","author":"A Schmid","year":"2020","unstructured":"Schmid A, Gehl J, Thomalla M, Hochberg A, Krei\u00df A, Patz M, Karrasch T, Sch\u00e4ffler A (2020) Downregulation of ctrp-3 by weight loss in vivo and by bile acids and incretins in adipocytes in vitro. Int J Mol Sci 21(21):8168. https:\/\/doi.org\/10.3390\/ijms21218168","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2426_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cyto.2012.01.018","volume":"58","author":"M Otani","year":"2012","unstructured":"Otani M, Kogo M, Furukawa S, Wakisaka S, Maeda T (2012) The adiponectin paralog C1q\/TNF-related protein 3 (CTRP3) stimulates testosterone production through the cAMP\/PKA signaling pathway. Cytokine 58(2):238\u2013244. https:\/\/doi.org\/10.1016\/j.cyto.2012.01.018","journal-title":"Cytokine"},{"key":"2426_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-018-0753-7","volume":"20","author":"RE Davies","year":"2018","unstructured":"Davies RE, Rier JD (2018) Gender Disparities in CAD: Women and Ischemic Heart Disease. Curr Atheroscler Rep 20:1\u20137. https:\/\/doi.org\/10.1007\/s11883-018-0753-7","journal-title":"Curr Atheroscler Rep"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02426-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02426-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T07:03:20Z","timestamp":1714201400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02426-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2426"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02426-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local Ethics Committee at the University of Marburg (245\u201312).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}